检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
出 处:《药学实践杂志》2011年第4期241-246,255,共7页Journal of Pharmaceutical Practice
摘 要:目的介绍试验设计-建模与优化方法在制剂研究中的重要作用。方法通过对国内外发表的关于制剂提取工艺及处方优化方面的诸多文献进行归纳、总结,明确试验设计-建模与优化方法在制剂研究中的重要作用,并简评其最新应用进展。结果对制剂研究中面临的一些复杂优化问题,试验设计-建模与优化方法能够依据试验设计方法,科学合理地安排试验点,并通过建模,将试验结果与影响因素之间隐藏的内在规律用数学模型抽象化地表达出来,进而通过对数学模型的优化研究,找到最优的结果及条件以解决这些复杂优化问题。结论随着研究水平的不断提高以及多学科交叉的日益深入,制剂研究中将面临着更多的多因素、多水平的复杂的优化问题,而试验设计-建模与优化方法也必将在制剂研究中得到更为广泛的应用。Objective To illustrate the importance of chemometrics tools(experimental design combined with modeling and optimization) in the study on pharmaceutical preparations.Methods A wide range of publications associated with extraction condition and prescription optimizations were reviewed.It was found that the combined optimization methodology mentioned above played a very important role in the study of pharmaceutical preparations.Results The methodology based on the combination of experimental design,modeling and optimization,was a very effective tool for solving the complex optimization problems in pharmaceutical studies.With the help of experimental design,all experimental points could be arranged scientifically and reasonably,and thus in turn,only a minimal of experimental points were required;with the assist of mathematical modeling,the immanence disciplines between the experimental results and its corresponding experimental factors could be abstractively expressed and interpreted via mathematical model;with the aid of optimization,the optimal results as well as its corresponding conditions could be finally predicted.Conclusion With the rapid development of pharmaceutical preparations and its integration with other cross-disciplines,there would be more and more complex nonlinear problems which could make a wider use of the proposed combined optimization methodology.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15